.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Merck
Fish and Richardson
Boehringer Ingelheim
Harvard Business School
Baxter
Accenture
US Army
Chinese Patent Office

Generated: July 21, 2017

DrugPatentWatch Database Preview

TROVAN/ZITHROMAX COMPLIANCE PAK Drug Profile

« Back to Dashboard

What is the patent landscape for Trovan/zithromax Compliance Pak, and when can generic versions of Trovan/zithromax Compliance Pak launch?

Trovan/zithromax Compliance Pak is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in TROVAN/ZITHROMAX COMPLIANCE PAK is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-one drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.

Summary for Tradename: TROVAN/ZITHROMAX COMPLIANCE PAK

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list2,067
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TROVAN/ZITHROMAX COMPLIANCE PAK at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TROVAN/ZITHROMAX COMPLIANCE PAK
azithromycin dihydrate; trovafloxacin mesylate
FOR SUSPENSION, TABLET;ORAL050762-001Dec 18, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
McKinsey
Farmers Insurance
Harvard Business School
Dow
Cantor Fitzgerald
Queensland Health
Fish and Richardson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot